BioCentury
ARTICLE | Company News

Baruch S. Blumberg Institute, OnCore Biopharma deal

January 5, 2015 8:00 AM UTC

The institute granted OnCore an exclusive, worldwide option to license products resulting from the partners’ collaboration to identify HBV and liver cancer targets, therapies and diagnostics. Under th...